Preventive Versus Curative Platelet Transfusion Strategies in the Treatment of Acute Myeloid Leukemia Patients: A Comparative StudyAude Charbonnier, Mauricette Michallet, Anne Etienne et al.|Blood|2014Cited by 1
Therapeutic Management of Acute Myeloid Leukemia Patients after Stratification on Age, Prognosis and Allogeneic Hematopoietic Stem Cell Transplantation EligibilityMauricette Michallet, Xavier Thomas, Mohamad Sobh et al.|Blood|2014Cited by 1
A Significant Early Detection Of Poor Outcome In Acute Myeloid Leukemia Patients Having a Minimal Residual Disease Using Multiparameter Flow Cytomerty Combined To Mixed Chimerism At Three Months After Allogeneic Hematopoietic Stem Cell TransplantationFlorence Beckerich, Mauricette Michallet, Mohamad Sobh et al.|Blood|2013Cited by 0
Survey of Serum Aspergillus Antigen in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia or Allogeneic Hematopoietic Stem Cell Transplantation: Role in Predicting Invasive Aspergillosis and in Modifying the Therapeutic StrategyV. Tran, Mauricette Michallet, Florence Persat et al.|Blood|2015Cited by 0
First Results of a Prospective Study on Erythropoietin Biosimilar (Epoetin zeta) Use in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematological MalignanciesMauricette Michallet, Franck E. Nicolini, Mohamad Sobh et al.|Blood|2015Cited by 0